Out-of-pocket expenditures and financial risks associated with treatment of vaccine-preventable diseases in Ethiopia: A cross-sectional costing analysis

• Published in: PLoS medicine Vol. 20; no. 3; p. e1004198
• Main Authors: Memirie, Solomon Tessema, Tolla, Mieraf Taddesse, Rumpler, Eva, Sato, Ryoko, Bolongaita, Sarah, Tefera, Yohannes Lakew, Tesfaye, Latera, Tadesse, Meseret Zelalem, Getnet, Fentabil, Mengistu, Tewodaj, Verguet, Stéphane
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 10-03-2023; Public Library of Science (PLoS)
• Subjects: Bacterial pneumonia; BCG; BCG vaccines; Catastrophic Illness; Child; Cross-Sectional Studies; Diarrhea; Ethiopia; Health Expenditures; Health facilities; Households; Humans; Immunization; Measles; Medical care, Cost of; Medicine and Health Sciences; Meningitis; Morbidity; Mortality; People and Places; Pertussis; Pneumonia; Social Sciences; Statistical analysis; Vaccination; Vaccine-Preventable Diseases; Vaccines; Whooping Cough; Ethiopia; Uganda; Africa; Addis Ababa Ethiopia
• ISSN: 1549-1676; 1549-1277; 1549-1676
• DOI: 10.1371/journal.pmed.1004198

Vaccine-preventable diseases (VPDs) remain major causes of morbidity and mortality in low- and middle-income countries (LMICs). Universal access to vaccination, besides improved health outcomes, would substantially reduce VPD-related out-of-pocket (OOP) expenditures and associated financial risks. This paper aims to estimate the extent of OOP expenditures and the magnitude of the associated catastrophic health expenditures (CHEs) for selected VPDs in Ethiopia.
We conducted a cross-sectional costing analysis, from the household (patient) perspective, of care-seeking for VPDs in children aged under 5 years for pneumonia, diarrhea, measles, and pertussis, and in children aged under 15 years for meningitis. Data on OOP direct medical and nonmedical expenditures (2021 USD) and household consumption expenditures were collected from 995 households (1 child per household) in 54 health facilities nationwide between May 1 and July 31, 2021. We used descriptive statistics to measure the main outcomes: magnitude of OOP expenditures, along with the associated CHE within households. Drivers of CHE were assessed using a logistic regression model. The mean OOP expenditures per disease episode for outpatient care for diarrhea, pneumonia, pertussis, and measles were $5·6 (95% confidence interval (CI): $4·3, 6·8), $7·8 ($5·3, 10·3), $9·0 ($6·4, 11·6), and $7·4 ($3·0, 11·9), respectively. The mean OOP expenditures were higher for inpatient care, ranging from $40·6 (95% CI: $12·9, 68·3) for severe measles to $101·7 ($88·5, 114·8) for meningitis. Direct medical expenditures, particularly drug and supply expenses, were the major cost drivers. Among those who sought inpatient care (345 households), about 13·3% suffered CHE, at a 10% threshold of annual consumption expenditures. The type of facility visited, receiving inpatient care, and wealth were significant predictors of CHE (p-value < 0·001) while adjusting for area of residence (urban/rural), diagnosis, age of respondent, and household family size. Limitations include inadequate number of measles and pertussis cases.
The OOP expenditures induced by VPDs are substantial in Ethiopia and disproportionately impact those with low income and those requiring inpatient care. Expanding equitable access to vaccines cannot be overemphasized, for both health and economic reasons. Such realization requires the government's commitment toward increasing and sustaining vaccine financing in Ethiopia.